Top news of the week: 19.04.2022.
Startups
Responding To Tough Markets: Restructurings In Biotech
Another day, another “restructuring” – there’s been a flurry of press releases recently using phrases like “exploring strategic alternatives”, “extending the cash runway”, and ...
Location, Location, Location. Entrepreneurs, Where You Locate Your Startup Might Be As Important As The Timing
Several startup ecosystems, outside of Silicon Valley, have been quietly rising for more than 20 years.
Troubling data leads a biotech to pull its prized drug from market and FDA review
Early analysis of a key clinical trial showed a potentially increased risk of death in cancer patients who received a combination treatment that included TG Therapeutics' approved medicine, ...
Imara to reduce staff by 83% amid biotech shakeout
The planned job cuts were announced days after Imara — one of three spinouts from the drug accelerator Cydan Development — stopped development of its top medicine.
GSK acquires Sierra Oncology, betting $2B on a bone cancer drug with a long history
The British pharma is buying into the potential of a medicine meant to treat the anemia often associated with myelofibrosis, a complication that isn't adequately addressed by current ...
Pitching the Science of Tomorrow: How to Win in a Bear Market
Join us on April 21st, 2022 @ 1pm ET for a candid chat with three major investors from our biotechnology community. Gain valuable insights and be ready to ace pitching world-changing ...
Ansa Biotechnologies Raises $68 Million In Series A Funding
Ansa Biotechnologies recently announced it raised a $68 million round of funding. These are the details.
Alzheimer’s Drug Developer Alzheon Secures $50 Million
The Framingham, Mass.-based biotech company is testing the drug in late-stage, Phase 3 clinical trials.